Valuation: biote Corp.

Market Cap 42.44M 36.36M 34.02M 31.14M 58.44M 4.06B 59.21M 402M 157M 2.04B 159M 156M 6.75B P/E 2026 *
-7.22x
P/E 2027 * 8.71x
Enterprise Value 42.44M 36.36M 34.02M 31.14M 58.44M 4.06B 59.21M 402M 157M 2.04B 159M 156M 6.75B EV / Sales 2026 *
0.24x
EV / Sales 2027 * 0.23x
Free-Float
85.16%
Yield 2026 *
-
Yield 2027 * -
1 day+7.77%
1 week+8.50%
Current month-29.11%
1 month-36.71%
3 months-22.95%
6 months-22.20%
Current year-38.65%
1 week 1.3
Extreme 1.3
1.68
1 month 1.3
Extreme 1.3
2.53
Current year 1.27
Extreme 1.27
2.68
1 year 1.27
Extreme 1.27
3.62
3 years 1.27
Extreme 1.27
8.44
5 years 1.27
Extreme 1.27
10.52
10 years 1.27
Extreme 1.27
10.52
Manager TitleAgeSince
Chief Executive Officer 49 12/06/2026
Chief Tech/Sci/R&D Officer 69 01/03/2024
Sales & Marketing - -
Director TitleAgeSince
Chairman 61 01/05/2022
Director/Board Member 51 01/05/2022
Director/Board Member 63 01/05/2022
Date Insider Type Main position Quantity % Market Cap.
11/08/26 Buy

Chairman

16,000 0.0528%
09/06/25 Free

Director

150,439 0.4601%
13/05/25 Fiscal year

Director

148,044 0.4527%
Change 5-day change 1-year change 3-year change Capi.($)
+9.12%+8.50%-47.19%-67.84% 42.44M
+1.32%-3.25%-17.03%+16.94% 132M
+9.22%+4.61%-27.04%-91.80% 83.57M
Average +6.21%-3.88%-30.42%-47.57% 86.02M
Weighted average by Cap. +5.04%-4.51%-25.23%-32.22%

Financials

2026 *2027 *
Net sales 178M 152M 143M 131M 245M 17.02B 248M 1.68B 657M 8.55B 668M 654M 28.29B 188M 161M 150M 138M 258M 17.95B 262M 1.78B 693M 9.02B 704M 689M 29.83B
Net income -5.99M -5.13M -4.8M -4.4M -8.25M -573M -8.36M -56.75M -22.13M -288M -22.5M -22.01M -953M 3.76M 3.23M 3.02M 2.76M 5.18M 360M 5.25M 35.65M 13.9M 181M 14.14M 13.83M 599M
Net Debt - -
Logo biote Corp.
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Employees
223
Date Price Change Volume
21/08/26 $1.595 +7.77% 220,542
20/08/26 $1.480 +8.82% 2,174,740
19/08/26 $1.360 +4.62% 91,434
18/08/26 $1.300 -5.11% 230,158
17/08/26 $1.370 -6.80% 161,372
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.480USD
Average target price
2.612USD
Spread / Average Target
+76.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BTMD Stock